Overview

Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged sedation (> 24 hours) in critically ill patients who require mechanical ventilation.
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Collaborators:
Hospira, Inc.
Hospira, now a wholly owned subsidiary of Pfizer
Treatments:
Dexmedetomidine
Fentanyl
Midazolam
Propofol